C

Corden Pharma Brussels (Public limited company)

BE 0430.891.915 In liquidation ●Avenue Louise 523, 1050 Bruxelles

Corden Pharma Brussels is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0430.891.915. It was founded on 09-04-1987. Its registered office is in Brussels. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2024 report equity of € -38 057 573 and a loss of € 11 795 570. These accounts report 51.5 full-time equivalents. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 2 of its last 4 financial years.

Information last updated on 07-10-2026.

Company information

Status
In liquidation
Enterprise number
BE 0430.891.915
VAT registered
Yes
Founded
09-04-1987
Latest accounts
2024
Employees
51.5 FTE
Region
Brussels-Capital
Establishments
1
Filing record
On time 2 of 4 years
Peppol e-invoicing
Not registered
Registered office
Avenue Louise 523, 1050 Bruxelles
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21100 Fabrication de produits pharmaceutiques de base
20140 Fabrication d’autres produits chimiques organiques de base

Key figures of Corden Pharma Brussels

2024202320222021
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -11 795 570+61 %€ -30 549 557€ 735 406-88 %€ 5 972 713
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ -38 057 573-45 %€ -26 262 003€ 4 287 554+21 %€ 3 552 148
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 1 222 796-88 %€ 10 214 668-55 %€ 22 669 641+23 %€ 18 422 471
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
----
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
51.5-47 %97.2+15 %84.3+13 %74.7

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
7 mandates on record in the annual accounts. 1 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity in Brussels.

CompanyTown
Pfizer 1050 Ixelles
Besins Manufacturing Belgium 1050 Ixelles
Collabor - Buro Intérim 1050 Ixelles
Belphar 1050 Ixelles
Limea 1050 Ixelles
Withers en Gerke (Europa) 1050 Ixelles
Progeco 1050 Bruxelles
International Design Company (I.D.C.) 1050 Ixelles
Looking for more information about Corden Pharma Brussels?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Corden Pharma Brussels still active? Corden Pharma Brussels is still registered but in liquidation, according to the Crossroads Bank for Enterprises.

What is the VAT number of Corden Pharma Brussels? The VAT number of Corden Pharma Brussels is BE 0430.891.915.

When was Corden Pharma Brussels founded? Corden Pharma Brussels was founded on 09-04-1987.

What is the address of Corden Pharma Brussels? The current registered office of Corden Pharma Brussels is Avenue Louise 523, 1050 Bruxelles.

When did Corden Pharma Brussels last file annual accounts? The latest annual accounts of Corden Pharma Brussels were filed on 24-09-2025.

Does Corden Pharma Brussels file its annual accounts on time? Corden Pharma Brussels filed its annual accounts within the legal deadline for 2 of its last 4 financial years. Late: 2023, 2024.

How many employees does Corden Pharma Brussels have? Corden Pharma Brussels employs 51.5 full-time equivalents according to its most recent annual accounts.

Is Corden Pharma Brussels financially healthy? Addrly gives Corden Pharma Brussels a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Corden Pharma Brussels profitable? The annual accounts of Corden Pharma Brussels for 2024 show a loss of € 11 795 570.

What is the equity of Corden Pharma Brussels? The equity of Corden Pharma Brussels was € -38 057 573 at the close of the 2024 financial year.

Who are the directors of Corden Pharma Brussels? The annual accounts of Corden Pharma Brussels record 7 mandates. The names, roles and dates are visible with a free account.

Can Corden Pharma Brussels receive Peppol e-invoices? Corden Pharma Brussels is not registered on the Peppol network at the moment.

What does Corden Pharma Brussels do? The main activity of Corden Pharma Brussels is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data